• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Rapastinel Is a FAILURE just like Saunders and AGN





















What about territories that already have a CNS2 in place? Those that have CNS2 overlap now have three reps calling on high volume psychiatrists with same drugs and offices hate it